Viatris Inc. (VTRS)

Market Cap	10.50B
Revenue (ttm)	14.33B
Net Income (ttm)	-3.79B
Shares Out	1.17B
EPS (ttm)	-3.18
PE Ratio	n/a
Forward PE	3.90
Dividend	$0.48 (5.37%)
Ex-Dividend Date	May 23, 2025

Volume	11,583,773
Open	8.95
Previous Close	8.77
Day's Range	8.92 - 9.11
52-Week Range	6.85 - 13.55
Beta	0.89
Analysts	Hold
Price Target	10.50 (+17.32%)
Earnings Date	May 8, 2025

About VTRS

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1961
• Employees: 32,000
• Stock Exchange: NASDAQ
• Ticker Symbol: VTRS
• Website: https://www.viatris.com

Analyst Forecast

According to 4 analysts, the average rating for VTRS stock is "Hold." The 12-month stock price forecast is $10.5, which is an increase of 17.32% from the latest price.

Price Target

$10.5

(17.32% upside)

Analyst Consensus: Hold